• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小细胞外囊泡中的miR-33a-5p作为人结肠癌细胞中奥沙利铂敏感性的非侵入性生物标志物。

miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells.

作者信息

Tanaka Shota, Hosokawa Mika, Miyamoto Takumi, Nakagawa Aiko, Haruna Mika, Ueda Kumiko, Iwakawa Seigo, Ogawara Ken-Ichi

出版信息

Biochem Biophys Rep. 2021 Apr 7;26:100996. doi: 10.1016/j.bbrep.2021.100996. eCollection 2021 Jul.

DOI:10.1016/j.bbrep.2021.100996
PMID:33898768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8058522/
Abstract

microRNAs (miRNAs) contained in small extracellular vesicles (sEVs) are candidates for non-invasive biomarkers. Oxaliplatin (L-OHP) has been approved for advanced colorectal cancer (CRC) chemotherapy. However, the response to L-OHP differs among CRC patients. In addition, CRC cells often acquire the resistance to L-OHP. This study aimed at the prediction of L-OHP sensitivity by measuring extracellular miRNAs levels. Firstly, we compared intracellular miRNAs expressions in L-OHP-sensitive CRC cells (SW620 and HCT116 cells) with those in acquired and intrinsic L-OHP-resistant cells. In microarray and real-time RT-PCR analyses, the intracellular miR-33a-5p, miR-210-3p, and miR-224-5p expressions were lower in acquired and intrinsic L-OHP-resistant CRC cells than sensitive cells. Furthermore, in SW620 cells, L-OHP sensitivity was decreased by miR-33a-5p inhibitor. On the other hand, miR-210-3p or miR-224-5p inhibitor did not affect L-OHP sensitivity in SW620 cells. Secondly, the amount of miR-33a-5p, miR-210-3p, and miR-224-5p in sEVs was compared. The amount of miR-33a-5p and miR-210-3p in sEVs secreted from acquired and intrinsic L-OHP-resistant cells tended to be small. miR-224-5p was not detected in sEVs secreted from three types of CRC cells examined. To the best of our knowledge, this is the first study demonstrating that miR-33a-5p and/or miR-210-3p in sEVs would be candidates for biomarkers of L-OHP sensitivity. In particular, miR-33a-5p is a promising candidate because it would be directly involved in L-OHP sensitivity.

摘要

小细胞外囊泡(sEVs)中含有的微小RNA(miRNAs)是非侵入性生物标志物的候选者。奥沙利铂(L-OHP)已被批准用于晚期结直肠癌(CRC)的化疗。然而,CRC患者对L-OHP的反应各不相同。此外,CRC细胞常常会对L-OHP产生耐药性。本研究旨在通过测量细胞外miRNAs水平来预测对L-OHP的敏感性。首先,我们比较了L-OHP敏感的CRC细胞(SW620和HCT116细胞)与获得性和固有性L-OHP耐药细胞中的细胞内miRNAs表达。在微阵列和实时RT-PCR分析中,获得性和固有性L-OHP耐药的CRC细胞中的细胞内miR-33a-5p、miR-210-3p和miR-224-5p表达低于敏感细胞。此外,在SW620细胞中,miR-33a-5p抑制剂降低了L-OHP敏感性。另一方面,miR-210-3p或miR-224-5p抑制剂对SW620细胞中的L-OHP敏感性没有影响。其次,比较了sEVs中miR-33a-5p、miR-210-3p和miR-224-5p的含量。获得性和固有性L-OHP耐药细胞分泌的sEVs中miR-33a-5p和miR-210-3p的含量往往较少。在所检测的三种CRC细胞分泌的sEVs中未检测到miR-224-5p。据我们所知,这是第一项证明sEVs中的miR-33a-5p和/或miR-210-3p可能是L-OHP敏感性生物标志物候选者的研究。特别是,miR-33a-5p是一个有前景的候选者,因为它可能直接参与L-OHP敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/e1abb9d68aae/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/f9a4e584dab4/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/a0c6c4461a82/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/384fee7a6472/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/e8cfaadde5ce/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/e1abb9d68aae/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/f9a4e584dab4/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/a0c6c4461a82/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/384fee7a6472/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/e8cfaadde5ce/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49ab/8058522/e1abb9d68aae/gr4.jpg

相似文献

1
miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells.小细胞外囊泡中的miR-33a-5p作为人结肠癌细胞中奥沙利铂敏感性的非侵入性生物标志物。
Biochem Biophys Rep. 2021 Apr 7;26:100996. doi: 10.1016/j.bbrep.2021.100996. eCollection 2021 Jul.
2
miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.miR-200b-3p 通过靶向 TUBB3 减轻结直肠癌细胞对奥沙利铂的耐药性。
J Gene Med. 2020 Jul;22(7):e3178. doi: 10.1002/jgm.3178. Epub 2020 Mar 11.
3
SIRT1 enhances oxaliplatin resistance in colorectal cancer through microRNA-20b-3p/DEPDC1 axis.SIRT1 通过 microRNA-20b-3p/DEPDC1 轴增强结直肠癌对奥沙利铂的耐药性。
Cell Biol Int. 2022 Dec;46(12):2107-2117. doi: 10.1002/cbin.11905. Epub 2022 Oct 6.
4
The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy.血浆miR-33a-5p作为结直肠癌化疗疗效预测生物标志物的有效性。
Oncol Lett. 2021 Jun;21(6):489. doi: 10.3892/ol.2021.12749. Epub 2021 Apr 22.
5
MiR-153-5p promotes sensibility of colorectal cancer cells to oxaliplatin via targeting Bcl-2-mediated autophagy pathway.miR-153-5p 通过靶向 Bcl-2 介导的自噬通路促进结直肠癌细胞对奥沙利铂的敏感性。
Biosci Biotechnol Biochem. 2020 Aug;84(8):1645-1651. doi: 10.1080/09168451.2020.1760784. Epub 2020 May 7.
6
Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.奥沙利铂耐药结直肠癌细胞中上皮-间质转化的诱导及miR-200c和miR-141的下调
Biol Pharm Bull. 2015;38(3):435-40. doi: 10.1248/bpb.b14-00695. Epub 2014 Dec 27.
7
MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.微小 RNA-33a-5p 通过抑制 MTHFD2 抑制结直肠癌细胞生长。
Clin Exp Pharmacol Physiol. 2019 Oct;46(10):928-936. doi: 10.1111/1440-1681.13125. Epub 2019 Jul 22.
8
A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.全血中两个 miRNA 标志物(miR-33a-5p 和 miR-128-3p)可作为肺癌早期诊断的潜在生物标志物。
Sci Rep. 2018 Nov 12;8(1):16699. doi: 10.1038/s41598-018-35139-3.
9
A test of miR-128-3p and miR-33a-5p in serum exosome as biomarkers for auxiliary diagnosis of non-small cell lung cancer.检测血清外泌体中的miR-128-3p和miR-33a-5p作为非小细胞肺癌辅助诊断生物标志物的研究
J Thorac Dis. 2023 May 30;15(5):2616-2626. doi: 10.21037/jtd-23-398. Epub 2023 May 23.
10
[MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].[微小RNA-145通过调节G蛋白偶联受体98抑制大肠癌细胞对奥沙利铂的耐药性]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 May 25;20(5):566-570.

引用本文的文献

1
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy.哺乳动物癌症干细胞耐药性的综合综述:对癌症治疗的启示
Cancer Cell Int. 2024 Dec 18;24(1):406. doi: 10.1186/s12935-024-03558-0.
2
Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis.天然产物的辐射调节功能与靶向辐射调节和外泌体生物发生的 miRNAs 之间的联系。
Int J Mol Sci. 2023 Aug 4;24(15):12449. doi: 10.3390/ijms241512449.
3
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.

本文引用的文献

1
Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease.用于准确检测肝病患者肝细胞癌的高灵敏度循环微小RNA检测板
Hepatol Commun. 2019 Dec 19;4(2):284-297. doi: 10.1002/hep4.1451. eCollection 2020 Feb.
2
Systematic review: exosomal microRNAs associated with pancreatic cancer for early detection and prognosis.系统评价:与胰腺癌相关的外泌体 microRNAs 用于早期检测和预后。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9351-9361. doi: 10.26355/eurrev_201911_19428.
3
Exosomes derived from miR-146a-modified adipose-derived stem cells attenuate acute myocardial infarction-induced myocardial damage via downregulation of early growth response factor 1.
液体活检在结直肠癌的检测、预后和进展监测前沿。
Mol Cancer. 2022 Mar 25;21(1):86. doi: 10.1186/s12943-022-01556-2.
4
The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance.外泌体非编码 RNA 在结直肠癌药物耐药中的作用
Int J Mol Sci. 2022 Jan 27;23(3):1473. doi: 10.3390/ijms23031473.
来源于 miR-146a 修饰的脂肪来源干细胞的外泌体通过下调早期生长反应因子 1 减轻急性心肌梗死诱导的心肌损伤。
J Cell Biochem. 2019 Mar;120(3):4433-4443. doi: 10.1002/jcb.27731. Epub 2018 Oct 26.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.miR-33a 通过靶向 PIM1 对喉癌细胞 Hep-2 的抗增殖作用。
Head Neck. 2018 Nov;40(11):2455-2461. doi: 10.1002/hed.25361. Epub 2018 Aug 13.
6
Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients.鉴定miR-16作为慢性肾脏病患者尿液外泌体miRNA表达数据标准化的内参基因。
PLoS One. 2017 Aug 31;12(8):e0183435. doi: 10.1371/journal.pone.0183435. eCollection 2017.
7
Altered miR-155 Expression in Allergic Asthmatic Airways.变应性哮喘气道中miR-155表达的改变
Scand J Immunol. 2017 Apr;85(4):300-307. doi: 10.1111/sji.12535.
8
The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting.RNA结合蛋白SYNCRIP是控制微小RNA分选的肝细胞外泌体机制的一个组成部分。
Cell Rep. 2016 Oct 11;17(3):799-808. doi: 10.1016/j.celrep.2016.09.031.
9
Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis.细胞外囊泡抑制自噬促进 COPD 发病机制中的肌成纤维细胞分化。
J Extracell Vesicles. 2015 Nov 11;4:28388. doi: 10.3402/jev.v4.28388. eCollection 2015.
10
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.信使核糖核酸结合蛋白HuR通过对胰腺癌细胞中原癌基因PIM1的转录后调控促进缺氧诱导的化疗耐药性。
Oncogene. 2016 May;35(19):2529-41. doi: 10.1038/onc.2015.325. Epub 2015 Sep 21.